BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 14697379)

  • 1. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
    Fan G; Sun B; Wu Z; Guo Q; Guo Y
    Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-ischemic encephalopathy in full-term neonate: correlation proton MR spectroscopy with MR imaging.
    Fan G; Wu Z; Chen L; Guo Q; Ye B; Mao J
    Eur J Radiol; 2003 Feb; 45(2):91-8. PubMed ID: 12536086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
    Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
    Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative study of MR T1 and T2 relaxation times and 1HMRS in gray matter of normal adult brain.
    Fan G; Wu Z; Pan S; Guo Q
    Chin Med J (Engl); 2003 Mar; 116(3):400-4. PubMed ID: 12781046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
    Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.
    Kaminogo M; Ishimaru H; Morikawa M; Ochi M; Ushijima R; Tani M; Matsuo Y; Kawakubo J; Shibata S
    Neuroradiology; 2001 May; 43(5):353-63. PubMed ID: 11396738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
    Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
    Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.
    Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Catapano D; Giannatempo GM; Bonavita S; Portaluri M; Tosetti M; d'Angelo VA; Salvolini U; Tedeschi G
    Eur Radiol; 2008 Aug; 18(8):1727-35. PubMed ID: 18389246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.
    Ankush A; Sardessai S
    Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
    Bartha R; Megyesi JF; Watling CJ
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.